Navigation Links
Alpine Biomed Acquires Stellate to Create New Leader in Neurology Diagnostics Market
Date:1/15/2009

FOUNTAIN VALLEY, Calif., Jan. 15 /PRNewswire/ -- Alpine Biomed Corporation, a global leader in specialty diagnostic devices, announced today that it has acquired Stellate Systems Inc. Headquartered in Montreal, Quebec, Stellate specializes in the development and production of advanced neurodiagnostic systems. The acquisition is the second that Alpine Biomed has completed since Water Street Healthcare Partners, a leading private equity firm focused exclusively on health care, invested in the company in 2007.

The combination significantly increases the size of Alpine Biomed's neurology business and gives the company a strong foothold in the rapidly growing sleep diagnostics market. Estimated to affect as many as 40 million Americans, sleep disorders have become one of the nation's top health conditions requiring diagnosis and treatment. Alpine Biomed will also offer products and software that detect and monitor a range of conditions including epilepsy and muscular disorders such as carpal tunnel syndrome. Additionally, Stellate's strength in research and development will enhance Alpine's product development capabilities.

"Acquiring Stellate marks an important step toward achieving our goal of becoming one of the world's leading specialty diagnostic device companies," said Alpine Biomed President and CEO John Arnott. "In addition to being a leader in the gastroenterology diagnostic market, Alpine Biomed is now a significant player in the neurodiagnostics market. We will offer our customers a comprehensive range of innovative products and software analytics that can diagnose and monitor a multitude of disorders with particular strength in the fast-growing area of sleep disorders."

Founded in 1986, Stellate designs, manufactures and distributes neurodiagnostic systems to hospitals, clinics and universities in more than 30 countries. It has pioneered many products, including the industry's
'/>"/>

SOURCE Alpine Biomed Corporation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. BioMed Realty Trust Reports Third Quarter 2007 Financial Results
9. LA BioMed research finds simpler way to assess breast cancer risk
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., Dec. 4 The following ...hysicians and Surgeons (AAPS): , ,DATE: ...,PLACE: Grand Hyatt Hotel Washington ... Renwick Room (lower level 2),EVENT: ...e, opposition to U.S. Senate he...
(Date:12/4/2009)...N and HOUSTON, Dec. 4 AE...(Nasdaq: CYBX ) announced today that Vagus Nerve... implantable medical device for the treatment of r...ations at the American Epilepsy Society,s (AES) A...ynes Convention Center in Boston, Massachusetts. ...
(Date:12/4/2009)... North American Seminars Inc. is now accepting med...al education courses at their medical facility in ...ts operation and capabilities to the medical commu...ate their physical therapy and occupational therap...over 250 live training events. , ...
(Date:12/4/2009)... Best-Selling author and Personal & Organizati...al Transformation through Accountability! , ...er 4, 2009 -- IMPAQ Accountability Business Cons..., best-selling Author, renowned Speaker, and CEO &...ultants Inc., will present at the 14th Internation...
(Date:12/3/2009)..., Dec. 3 The American R...International Brotherhood of Teamsters, Local 929 ...leaving the facility, interfering with blood shipm....newscom.com/cgi-bin/prnh/20081216/DC52619LOGO ) ...nst the American Red Cross Blood Services Penn-Jer...
Breaking Medicine News(10 mins):Health News:State Legislators in D.C. To Blast Senate Healthcare Bill at News Conference; Say Tramples States' Rights, and Saddles with Massive Medicaid Bills; Push Bills to Block Federal Mandates 2Health News:NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy 2Health News:NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:Mark Samuel, CEO & Founder, IMPAQ Accountability Business Consultants Inc., to Present at 14th ICF Annual International Conference 2Health News:American Red Cross Wins Court Injunction Against Striking Teamsters 2
...an., June 5 Fort Dodge Animal Health, a,division ...oduction of,ProHeart(R) 6, a unique heartworm prev...uncement follows a review by the U.S. Food and Dru...on,to return this life-saving product to the marke...
...Spot for the World,s Longest Indoor Stair Climb Be...on, CHICAGO, June 5 Registration for Go Vertical...o the top of the Sears,Tower, opens at 9 a.m. CDT ... is limited to the first 2,250 registrants, and wi...
... it possible to restore function to a paralyzed li...s disease? These are two of the several topics th...erence, June 16-18, hosted by Case Western Reserve...lready provided substantive benefits to many indiv...
... Three-Year Plan -, SAN ANTONIO, June 5 American...American Heartworm Society president, Dr.,Sheldon ... conduct the most,comprehensive heartworm incidenc...e through corporate sponsorship, will be,distribut...
...ely to smoke, abuse drugs, alcohol, study finds , ...ns with bipolar disorder are at greater risk of s...eneral Hospital (MGH) study that supports previous...uvenile delinquency," study leader Dr. Timothy Wil...
...cs effects of caloric restriction to extend life s...ay News) -- Resveratrol, a compound found in grape... may protect the heart and slow the effects of agi... percent fewer calories than a typical diet that h...
Other Medicine News:Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 2Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 3Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 4Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 5Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 2Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 3Health News:Premier conference on neurotechnology and deep brain stimulation to be held in Cleveland June 16-18 2Health News:American Heartworm Society Announces Heartworm Incidence Survey 2Health News:Bipolar Teens at Greater Risk of Substance Abuse 2Health News:Red Wine Compound Helps Heart, May Slow Aging 2
(Date:12/3/2009)... WALTHAM, Mass., Dec. 3 Decision...d advisory firms focusing on pharmaceutical and he...s drug market in Brazil will grow from $417 millio...5 percent annual growth rate is attributed to a gr...ased use of new generation antidiabetics such as M...
(Date:12/3/2009)...S ANGELES, Dec. 3 Instac...ovider of life-saving prescription drugs, home tes...ulfillment provider of direct to patient diabetes ...hnology and revolutionary cell phone centric techn... file multiple updated and enhanced patent and tra...
(Date:12/3/2009)...IEGO, Dec. 3 Amira Pharmaceutica...m a Phase 1 clinical study of AM461, the Company,s... known as CRTH2) receptor. ,, The interim res...dynamic (PD) effect can be achieved with AM461. A...es a good safety profile. AM461 is a back-up to A...
Breaking Medicine Technology:Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary MD@Hand Cell-Centric Products 2Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary MD@Hand Cell-Centric Products 3Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211 2MedNet Solutions Named to the Inc 5000 List Three Years in a Row 54901 1MedNet Solutions Named to the Inc 5000 List Three Years in a Row 54901 2Nutrisystem Now Offers Double the Fresh Frozen Food for the Same Low Monthly Cost 54898 1Nutrisystem Now Offers Double the Fresh Frozen Food for the Same Low Monthly Cost 54898 2Nutrisystem Now Offers Double the Fresh Frozen Food for the Same Low Monthly Cost 54898 3Treatment May Limit Graft Versus Host Disease 54894 1Treatment May Limit Graft Versus Host Disease 54894 2
... in Stable Asthma and Exercise-Induced ...ING, Pa., March 18 Genaera,Corporation (Nasdaq: ...Immune, has initiated its fourth phase 2a clinical...dy (MAb) targeting interleukin-9 (IL-9), in,patien... assess the,potential of MEDI-528 in patients with...
...icromet, Inc.,(Nasdaq: MITI ), a biopharmaceutica... for the treatment of cancer, inflammation and aut... be presented on April 14, 2008,at the annual meet...ACR) to,be held at the San Diego Convention Center...gress on the company,s proprietary BiTE(R) antibod...
Other Medicine Technology:Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 2Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 3Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 4Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 2Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 3Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 4Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 5
...ghly effective surgical alternative for the treatm...s positioned close to the high pressure zone of th...ree support of the urethra in the correct position...es, with minimal tissue dissection. Clinical studi...
...s, the PeaceKeeper 20 gauge multi-modality intraoc...Field comprehensive family of lightweight Eraser b... Combining highly effective bipolar hemostasis wit... in a single use, sterile instrument, the PeaceKee...
SUR-FIT® AutoLock® Urostomy Pouch with Accuseal® Tap
SUR-FIT Natura® Urostomy Pouch
Medicine Products: